Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Korean Red Ginseng Extract in Healthy Vietnamese Volunteers
NCT05480774Phase 1Completed
- Start
- Aug 2022
- Primary completion
- Dec 2022
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial (2 arms). Primary endpoint: Adverse events associated with the administration of KRG at 12 weeks. Started Aug 2022; status: completed.
Beyond the preview
Go deeper on NCT05480774.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05480774.